Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disorder Therapeutics Market Driver: A Major Catalyst in the Evolution of the Neurodegenerative Disorder Therapeutics Market in 2025

How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder cases, extended life expectancy, pharmaceutical companies' increasing investment, and greater awareness and advocacy initiatives.

The market size for therapeutics aimed at neurodegenerative disorders is anticipated to experience robust growth in the coming years, expected to reach $28.33 billion by 2029 with an estimated compound annual growth rate (CAGR) of 9.0%. This anticipated growth over the forecast period can be attributed to factors such as an increased demand for personalized medicine, availability of targeted therapies, a growing number of clinical trials, and a rise in healthcare expenditure. The forecast period also highlights significant trends such as the adoption of disease-altering therapies, non-drug interventions, the application of telemedicine and remote patient monitoring, technological advancements, precision therapies, digital healthcare solutions, and the use of biomarker-driven trials.

What Are the Key Drivers Behind the Growth of the Neurodegenerative Disorder Therapeutics Market?
The escalating occurrence of neurodegenerative diseases within the worldwide population is a significant contributor to the expansion of the neurodegenerative disorder therapeutics market. This surge is largely blamed on the growing elderly demographic, which is more prone to neurodegenerative conditions. To illustrate, the World Population Prospects predicted that by 2024, the demographic over 60 years of age will evolve to 2.1 billion by 2050. Simultaneously, those exceeding 80 years of age are expected to triple to 425 million in the same year. In the United States alone, the Alzheimer's Association reveals that nearly 5.8 million individuals are battling Alzheimer's disease, a figure anticipated to climb to an estimated 14 million by 2050. The escalating prevalence of these disorders within the aging demographic boosts the need for therapeutics in managing neurodegenerative diseases. Consequently, this fuels the growth of the neurodegenerative disorder therapeutics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp

Who Are the Major Industry Players Fueling Neurodegenerative Disorder Therapeutics Market Expansion?
Major companies operating in the neurodegenerative disorder therapeutics market include Biogen Inc., Pfizer Inc., Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB S.A., F. Hoffmann-La Roche Ltd., ACADIA Pharmaceuticals Inc., H. Lundbeck A/S, Boehringer Ingelheim International GmbH, Merck Serono S.A., Orion Corporation, Mitsubishi Tanabe Pharma America, Allergan PLC, GlaxoSmithKline PLC, AbbVie Inc., Eli Lilly and Company, Celgene Corporation, Neuro-Hitech Inc., Bayer Schering Pharma AG, Amarin Corporation PLC, AstraZeneca plc, Alector Inc., Yumanity Therapeutics Inc., Yangtze River Pharmaceutical Group Co. Ltd., Chongqing Zein Pharmaceutical Co. Ltd., Eisai Co. Ltd., Bristol Myers Squibb Company, AB Science S.A., Amylyx Pharmaceuticals Inc., Genentech Inc., GenSight Biologics S.A., AC Immune SA, Annexon Bioscience Inc., BioArctic Neuroscience AB, Cajal Neuroscience Inc., Cognito Therapeutics Inc., Grifols S.A., New Equilibrium Biosciences Inc., Prothena Corporation PLC, Tessera Therapeutics Inc., Vigil Neuroscience Inc.

Which Key Developments Are Influencing the Neurodegenerative Disorder Therapeutics Market?
Firms engaged in creating treatments for neurodegenerative disorders are initiating multiple strategic collaborations with both governmental and non-governmental entities to explore and establish therapies for an array of neurodegenerative diseases. These enterprises within the neurodegenerative disorder therapy market are enhancing their cooperative work with other market participants to augment their research and development efforts for devising newer and better therapeutic solutions for neurodegenerative disorders. For example, NRG Therapeutics, a pharmaceutical discovery company located in the UK and focused on therapeutic strategies, collaborated with Domainex, another UK-based drug discovery service, in July 2022, to establish treatments for neurodegenerative diseases. The collaboration aims to create novel small-molecule medications that can modify diseases like Parkinson's disease, motor neuron disease (MND), and other debilitating chronic neurodegenerative conditions.

How Is the Segmentation of the Neurodegenerative Disorder Therapeutics Market Defined?
The neurodegenerative disorder therapeutics market covered in this report is segmented -

1) By Indication Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Parkinson's Disease: Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics
2) By Alzheimer's Disease: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies
3) By Multiple Sclerosis: Immunomodulators, Immunosuppressants, Corticosteroids
4) By Huntington's Disease: Tetrabenazine, Antipsychotic Medications
5) By Other Indication Types: Amyotrophic Lateral Sclerosis (ALS) Treatments, Frontotemporal Dementia Treatments, Prion Disease Treatments

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

What Is the Leading Region in the Neurodegenerative Disorder Therapeutics Market?
The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Neurodegenerative Disorder Therapeutics Global Market Report?

- Market Size Analysis: Analyze the Neurodegenerative Disorder Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neurodegenerative Disorder Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neurodegenerative Disorder Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neurodegenerative Disorder Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.